DNA Study for WG Patients
Blood Donations Needed
The goal of Dr. Katherine Siminovitch’s study: ‘Identification of Novel Wegener’s Granulomatosis Susceptibility Genes’ is to identify the genes that confer risk for disease. The study has already identified variants in three of the genes studied and determined them to be significantly associated with WG. While we are continuing to assess other gene variants for their relevance to WG, the study needs at least 250 more WG patients to donate samples to have sufficient data to develop results.
It is very simple to participate in the study. Patients enroll in the study and have a blood sample drawn at their doctor’s office or laboratory and shipped to Dr. Siminovitch with the materials provided. If it is not convenient for you to have your blood drawn, we can send you a saliva kit – the saliva sample can be done in your own home.
Identification of WG susceptibility genes will provide a promising avenue to the development of improved diagnostic and prognostic tests, as well as new targets for therapeutic management.
All WG patients are eligible for the study, regardless of geographic location, age, and gender.
To learn more:
Research Coordinators: Jennifer / Stephanie
Phone: 416-946-4501 x3297
Mount Sinai Hospital
600 University Avenue